Jang, Yejin
Shin, Heegwon
Lee, Myoung Kyu
Kwon, Oh Seung
Shin, Jin Soo
Kim, Yong-il
Kim, Chan Woo
Lee, Hye-Ra
Kim, Meehyein
Funding for this research was provided by:
National Research Foundation of Korea
Korea Research Institute of Chemical Technology
Article History
Received: 22 July 2020
Accepted: 30 December 2020
First Online: 12 January 2021
Competing interests
: Y.J., H.S., M.K.L, O.S.K., J.S.S., C.W.K., H.-R.L., and M.K. declare no conflict of interest. Y.K. is trying to commercialize λ-CGN used in this study through the company Hanmi Pharmaceutical Co.